Prescription drug · ANDA
Mupirocin NDC 63187-151
Mupirocin 20 mg/g · Ointment · Topical · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63187-151-22 | 63187015122 | 1 TUBE in 1 CARTON (63187-151-22) / 22 g in 1 TUBEMarketed from Sep 1, 2014 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mupirocin
- Generic name (nonproprietary)
- mupirocin
- Active ingredients
- Mupirocin — 20 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065170
- Marketing start
- Listing expires
- Other FDA classes
- RNA Synthetase Inhibitors (Mechanism)
- Identifiers
- Product ID 63187-151_a22d9ce1-ccc1-4955-939c-b74e110cffa5SPL ID a22d9ce1-ccc1-4955-939c-b74e110cffa5SPL set ID d8766748-6b53-4673-a3ee-5cd8a4301647RxCUI 106346UNII D0GX863OA5UPC 0363187151225
- Pharmacologic class
- RNA Synthetase Inhibitor Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463187015122followed by a unit qualifier and the quantityPackage 63187-0151-22. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to: S. aureus and S. pyogenes .
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065170
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | Sportpharm LLC | 85766-207 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | NuCare Pharmaceuticals,Inc. | 68071-4321 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | Sun Pharmaceutical Industries, Inc. | 51672-1312 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | PAI Holdings, LLC dba PAI Pharma | 0121-1076 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | AvPAK | 50268-568 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0254 |
| Mupirocin | Mupirocin 20 mg/g | OintmentTopical | Lohxa | 70166-355 |